Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections (OTTER)
Clinical trial NCT03009045 · COMPLETED
Trial details
- NCT number
- NCT03009045
- Sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2021-03-23
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.